# This could be big: "Oura valued at $5B following deal with medical device firm Dexcom.

> Oura's $5B valuation following its deal with Dexcom signals a powerful convergence of continuous glucose monitoring and consumer wearables — and I think it could be a game-changer for health optimization well beyond diabetic patients.

URL: https://www.ch-healthtech.com/insights/could-be-big-oura-valued-5b-following-deal-medical-device-firm-dexcom
Markdown: https://www.ch-healthtech.com/insights/could-be-big-oura-valued-5b-following-deal-medical-device-firm-dexcom.md
Published: 2024-11-20
Updated: 2026-05-06
Author: Christian Hein
Tags: technology/connected-devices, technology/digital-health, industry/medtech, industry/digital-health-startups, function/innovation-management, activity/partnership-alliance

---


This could be big: "Oura valued at $5B following deal with medical device firm Dexcom."

Wow. The convergence of two major trends - continuous glucose monitoring (CGM), which is gaining traction even beyond diabetic patients, and the rise of consumer-friendly wearables - is truly intriguing.

This could be a game-changer - not just for managing chronic conditions but for overall health optimization; I could definitely see myself adopting this.

What do you think? Are we on the brink of a new wave of wearable health tech that could finally make potentially clinical-grade insights mainstream?

https://lnkd.in/egiKx_wJ